Chung Yuan Christian University (CYCU) continues advancing its Campus Science Park initiative with the official launch of its first research platform, the “Precision Medicine Co-Laboratory,” on May 22. Integrating bio-inspired bipolar interface technology with advanced membrane separation technologies, the laboratory aims to serve as a core hub for biomedical translational research and precision medicine innovation.
The unveiling ceremony was jointly hosted by CYCU President Lee Ying-Ming and Academia Sinica Academician Lee Wen-Hsiung, with representatives from academia, industry, and the university in attendance. President Lee stated that the establishment of the laboratory highlights CYCU’s achievements in interdisciplinary biomedical research and technological innovation, while also reflecting the university’s strong commitment to talent cultivation, industry-academia collaboration, and future technology development. He emphasized that universities should not only be centers of knowledge, but also important drivers of innovation and solutions to societal challenges.
Academia Sinica Academician Lee Wen-Hsiung noted that precision medicine—integrating genomics, bioinformatics, artificial intelligence, and clinical medicine—has become a major global trend in biomedical technology. He added that the establishment of the Precision Medicine Co-Laboratory reflects CYCU’s commitment to advancing cutting-edge biomedical research while providing a strong foundation for interdisciplinary collaboration and innovation.
Chang Yung, Director of CYCU’s Membrane Technology R&D Center and Office of Industry-Academia Operation, explained that the core strength of the Precision Medicine Co-Laboratory lies in integrating bio-inspired bipolar interface design with advanced membrane separation technologies. By mimicking the highly hydrated environment found in natural biological systems, the technology enhances anti-fouling performance and biocompatibility, making it especially effective for handling complex biological samples such as blood and plasma.
He further noted that exosomes have emerged as a key focus in precision medicine research due to their strong potential in disease diagnosis and drug delivery. Combined with advanced membrane separation technologies and precision instrumentation, the laboratory enables highly efficient separation and purification of nanoscale biological carriers, providing critical technical support for future clinical applications and precision medicine development.
CYCU’s Campus Science Park initiative focuses on six core research areas, including AI, cloud and quantum computing, sustainable innovation, and precision medicine, aiming to integrate interdisciplinary research and industry applications through shared research platforms.
The newly launched Precision Medicine Co-Laboratory will focus on major medical challenges such as neurodegenerative diseases, rare immune disorders, cancer treatment, and neural repair, while strengthening Taiwan’s biomedical R&D capabilities through interdisciplinary collaboration, industry partnerships, and talent cultivation. CYCU noted that the laboratory also marks the official launch of its Campus Science Park initiative and reflects the university’s long-term commitment to innovation and biomedical research development.
